Patents by Inventor Esteban R.N. Bornancini

Esteban R.N. Bornancini has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040091516
    Abstract: The invention includes dispensing a suspension containing solid particles for use in manufacturing a dosage form or other biomedical article by 3DP. The suspension contains solid particles suspended in a liquid. The solid particles may be one or more Active Pharmaceutical Ingredients. The solid particles may be particles of material that are insoluble in the liquid, or they may be particles of a substance that have already dissolved in the liquid up to the saturation level and are present in a concentration beyond what can be dissolved. In addition to solid particles, the liquid may also contain other substances dissolved in it, either substances containing Active Pharmaceutical Ingredients (API) or substances without API. One aspect of the invention includes prevention of agglomeration by adding one or more of several categories of additives to the suspending liquid.
    Type: Application
    Filed: November 3, 2003
    Publication date: May 13, 2004
    Applicants: Therics, Inc., Massachusetts Institute of Technology
    Inventors: Charles William Rowe, Wendy E. Pryce Lewis, Michael J. Cima, Esteban R.N. Bornancini, Jill K. Sherwood, Chen-Chao Wang, Christopher M. Gaylo, James A. Fairweather
  • Publication number: 20030099708
    Abstract: The invention includes dispensing a suspension containing solid particles for use in manufacturing a dosage form or other biomedical article by 3DP. The suspension contains solid particles suspended in a liquid. The solid particles may be one or more Active Pharmaceutical Ingredients. The solid particles may be particles of material that are insoluble in the liquid, or they may be particles of a substance that have already dissolved in the liquid up to the saturation level and are present in a concentration beyond what can be dissolved. In addition to solid particles, the liquid may also contain other substances dissolved in it, either substances containing Active Pharmaceutical Ingredients (API) or substances without API. One aspect of the invention includes prevention of agglomeration by adding one or more of several categories of additives to the suspending liquid.
    Type: Application
    Filed: November 21, 2001
    Publication date: May 29, 2003
    Applicant: Therics, Inc
    Inventors: Charles William Rowe, Wendy E. Pryce Lewis, Michael J. Cima, Esteban R.N. Bornancini, Jill K. Sherwood, Chen-Chao Wang, Christopher M. Gaylo, James A. Fairweather